Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB vs NITISINONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRSEVIMAB vs NITISINONE: Safety Overview

Metric NIRSEVIMAB NITISINONE
Total FAERS Reports 247 752
Deaths Reported 5 96
Death Rate 2.0% 12.8%
Hospitalizations 149 198
Average Patient Age 0.3 yrs 18.6 yrs
% Female Patients 42.3% 45.2%
FDA Approval Date N/A Apr 22, 2016
Manufacturer Sanofi Pasteur Inc. Bryant Ranch Prepack
Route INTRAMUSCULAR ORAL
Marketing Status N/A Prescription